Ubs Asset Management Americas Inc Zomedica Corp. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.2 - $0.34 $131,026 - $222,744
-655,130 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.28 - $0.4 $214,482 - $306,403
-766,008 Reduced 53.9%
655,130 $222,000
Q4 2021

Feb 14, 2022
BUY
$0.31 - $0.58 $266,543 - $498,694
859,818 Added 153.18%
1,421,138 $440,000
Q2 2021

Aug 16, 2021
BUY
$0.72 - $1.46 $404,150 - $819,527
561,320 New
561,320 $465,000

Others Institutions Holding ZOM

# of Institutions
87
Shares Held
80.9M
Call Options Held
0
Put Options Held
0
View Full List

About Zomedica Corp.

ZOM Quotes by TradingView
  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email